Revolution Medicines, Inc. RVMD Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s short-term investments?
- Revolution Medicines, Inc. (RVMD) reported short-term investments of $1.47B in Q1 2026.
- How has Revolution Medicines, Inc.'s short-term investments changed year-over-year?
- Revolution Medicines, Inc.'s short-term investments decreased by 17.1% year-over-year, from $1.77B to $1.47B.
- What is the long-term trend for Revolution Medicines, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s short-term investments has grown at a 37.3% compound annual growth rate (CAGR), from $336.47M to $1.64B.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.